BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 22869633)

  • 21. Evaluation of diagnostic performance of rK28 ELISA using urine for diagnosis of visceral leishmaniasis.
    Ghosh P; Bhaskar KR; Hossain F; Khan MA; Vallur AC; Duthie MS; Hamano S; Salam MA; Huda MM; Khan MG; Coler RN; Reed SG; Mondal D
    Parasit Vectors; 2016 Jul; 9(1):383. PubMed ID: 27377266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and comparative evaluation of two antigen detection tests for Visceral Leishmaniasis.
    Vallur AC; Tutterrow YL; Mohamath R; Pattabhi S; Hailu A; Abdoun AO; Ahmed AE; Mukhtar M; Salam MA; Almeida ML; Almeida RP; Mondal D; Albertini A; Ghalib H; Duthie MS; Reed SG
    BMC Infect Dis; 2015 Sep; 15():384. PubMed ID: 26395447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme-linked immunosorbent assay to detect urinary antibody against recombinant rKRP42 antigen made from Leishmania donovani for the diagnosis of visceral leishmaniasis.
    Islam MZ; Itoh M; Takagi H; Islam AU; Ekram AR; Rahman A; Takesue A; Hashiguchi Y; Kimura E
    Am J Trop Med Hyg; 2008 Oct; 79(4):599-604. PubMed ID: 18840751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short report: production of recombinant kinesin-related protein of Leishmania donovani and its application in the serodiagnosis of visceral leishmaniasis.
    Takagi H; Islam MZ; Itoh M; Islam AU; Saifuddin Ekram AR; Hussain SM; Hashiguchi Y; Kimura E
    Am J Trop Med Hyg; 2007 May; 76(5):902-5. PubMed ID: 17488913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology of visceral leishmaniasis in Bangladesh: prospects for improved control.
    Bern C; Chowdhury R
    Indian J Med Res; 2006 Mar; 123(3):275-88. PubMed ID: 16778310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leishmaniasis: current situation and new perspectives.
    Desjeux P
    Comp Immunol Microbiol Infect Dis; 2004 Sep; 27(5):305-18. PubMed ID: 15225981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan.
    Collin S; Davidson R; Ritmeijer K; Keus K; Melaku Y; Kipngetich S; Davies C
    Clin Infect Dis; 2004 Mar; 38(5):612-9. PubMed ID: 14986243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct agglutination test with urine samples for the diagnosis of visceral leishmaniasis.
    Islam MZ; Itoh M; Mirza R; Ahmed I; Ekram AR; Sarder AH; Shamsuzzaman SM; Hashiguchi Y; Kimura E
    Am J Trop Med Hyg; 2004 Jan; 70(1):78-82. PubMed ID: 14971702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visceral leishmaniasis: consequences of a neglected disease in a Bangladeshi community.
    Ahluwalia IB; Bern C; Costa C; Akter T; Chowdhury R; Ali M; Alam D; Kenah E; Amann J; Islam M; Wagatsuma Y; Haque R; Breiman RF; Maguire JH
    Am J Trop Med Hyg; 2003 Dec; 69(6):624-8. PubMed ID: 14740879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and levels of filaria-specific urinary IgG4 among children less than five years of age and the association of antibody positivity between children and their mothers.
    Weerasooriya MV; Itoh M; Islam MZ; Qiu XG; Fujimaki Y; Kimura E
    Am J Trop Med Hyg; 2003 Apr; 68(4):465-8. PubMed ID: 12875298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of ELISAs based on ten recombinant or purified Leishmania antigens for the serodiagnosis of Mediterranean visceral leishmaniasis.
    Maalej IA; Chenik M; Louzir H; Ben Salah A; Bahloul C; Amri F; Dellagi K
    Am J Trop Med Hyg; 2003 Mar; 68(3):312-20. PubMed ID: 12685637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory diagnosis of visceral leishmaniasis.
    Sundar S; Rai M
    Clin Diagn Lab Immunol; 2002 Sep; 9(5):951-8. PubMed ID: 12204943
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnosis of visceral leishmaniasis by enzyme-linked immunosorbent assay using urine samples.
    Islam MZ; Itoh M; Shamsuzzaman SM; Mirza R; Matin F; Ahmed I; Shamsuzzaman Choudhury AK; Hossain MA; Qiu XG; Begam N; Furuya M; Leafasia JL; Hashiguchi Y; Kimura E
    Clin Diagn Lab Immunol; 2002 Jul; 9(4):789-94. PubMed ID: 12093674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug development for neglected diseases: a deficient market and a public-health policy failure.
    Trouiller P; Olliaro P; Torreele E; Orbinski J; Laing R; Ford N
    Lancet; 2002 Jun; 359(9324):2188-94. PubMed ID: 12090998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen.
    Singh S; Kumari V; Singh N
    Clin Diagn Lab Immunol; 2002 May; 9(3):568-72. PubMed ID: 11986261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitive and specific enzyme-linked immunosorbent assay for the diagnosis of Wuchereria bancrofti infection in urine samples.
    Itoh M; Weerasooriya MV; Qiu G; Gunawardena NK; Anantaphruti MT; Tesana S; Rattanaxay P; Fujimaki Y; Kimura E
    Am J Trop Med Hyg; 2001 Oct; 65(4):362-5. PubMed ID: 11693885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis.
    Attar ZJ; Chance ML; el-Safi S; Carney J; Azazy A; El-Hadi M; Dourado C; Hommel M
    Acta Trop; 2001 Jan; 78(1):11-6. PubMed ID: 11164745
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.